SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

COSCIENS Biopharma Inc. Reports Q3 2026 Results and Provides Update On Convertible Debenture Offering

TORONTO, ONTARIO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. TSX:CSCI OTCQB:CSCIF (“COSCIENS” or the “Company”) today reported its financial and operating results for the third quarter ended September 30, 2026. All amounts in this press release are in U.S. dollars.Peter Puccetti, CEO…

CSCI

Related stories